Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectation and raises 2025 …
These Stocks Are Moving the Most Today: Sarepta, Verizon, Block, Tesla, Cleveland-Cliffs, DJT, Pinterest, and More
view original post